Exforge, INN: amlodipine / valsartan - European Medicines Agency
SCIENTIFIC DISCUSSION
1. Introduction
The proper management and control of blood pressure in hypertension patients, and the impact it has on associated morbidity and mortality rates, has been the focus of many new hypertension observational studies and clinical trials. These trials have demonstrated that more aggressive blood pressure lowering will reduce the complications associated with hypertension. As a result of this data, international guidelines for the management of hypertension now recommend a target blood pressure of ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- usa recall of all amlodipine valsartan combination tablets and
- comparison of high dose amlodipine with combination of low dose
- type drug recall
- torrent recall of valsartan containing products
- valsartan hctz valsartan amlodipine and valsartan amlodipine hctz cigna
- amlodipine valsartan
- valsartan and amlodipine and valsartan tablets
- exforge inn amlodipine valsartan european medicines agency
- real life safety and effectiveness of amlodipine valsartan combination
Related searches
- fda valsartan not recalled list
- valsartan hctz recall list
- valsartan recall 2019
- valsartan hydrochlorothiazide recall list
- agency vs non agency mbs
- list of valsartan not recalled
- why is valsartan unavailable
- agency identifier agency location code
- is valsartan still recalled
- amlodipine valsartan recall
- amlodipine valsartan 10 320
- amlodipine valsartan 5 160 recall